BCP
MDT icon

Blue Chip Partners’s Medtronic MDT Stock Holding History

Blue Chip Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-132,910
Closed -$10.7M – 184
2022
Q3 		$10.7M Buy
132,910
+3,570
+3% +$321K 1.47% 30
2022
Q2 		$11.6M Buy
129,340
+6,946
+6% +$704K 1.48% 33
2022
Q1 		$13.6M Sell
122,394
-824
-0.7% -$87.1K 1.69% 25
2021
Q4 		$12.7M Sell
123,218
-6,255
-5% -$724K 1.6% 28
2021
Q3 		$16.2M Buy
129,473
+4,526
+4% +$586K 2.28% 19
2021
Q2 		$15.5M Buy
124,947
+3,396
+3% +$426K 2.21% 20
2021
Q1 		$14.4M Sell
121,551
-515
-0.4% -$60.4K 2.21% 24
2020
Q4 		$14.3M Buy
122,066
+8,893
+8% +$979K 2.24% 24
2020
Q3 		$11.8M Buy
113,173
+2,788
+3% +$280K 2.09% 26
2020
Q2 		$10.1M Buy
110,385
+6,202
+6% +$595K 1.98% 27
2020
Q1 		$9.39M Sell
104,183
-5,251
-5% -$559K 2.33% 19
2019
Q4 		$12.4M Buy
109,434
+6,944
+7% +$762K 2.36% 10
2019
Q3 		$11.1M Buy
102,490
+3,788
+4% +$395K 2.35% 16
2019
Q2 		$9.61M Buy
98,702
+5,316
+6% +$485K 2.15% 17
2019
Q1 		$8.51M Buy
93,386
+16,702
+22% +$1.49M 2.01% 21
2018
Q4 		$6.97M Buy
76,684
+74,070
+2,834% +$6.92M 1.75% 18
2018
Q3 		$257K Buy
2,614
+687
+36% +$63.5K 0.06% 105
2018
Q2 		$165K Buy
1,927
+264
+16% +$22.1K 0.04% 120
2018
Q1 		$133K Buy
1,663
+133
+9% +$11K 0.04% 135
2017
Q4 		$124K Buy
1,530
+8
+0.5% +$641 0.04% 122
2017
Q3 		$118K Buy
+1,522
New +$126K 0.04% 122

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Blue Chip Partners's MDT Position: Q4 2022 in Review

Blue Chip Partners sold out of Medtronic (MDT) in Q4 2022, closing a stake of 132,910 shares — an estimated $10.7M sold.

Blue Chip Partners first reported a position in MDT in Q3 2017 and held it in 21 quarters. The position peaked at $16.2M in Q3 2021. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Blue Chip Partners reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • Blue Chip Partners sold 132,910 Medtronic shares in Q4 2022, an estimated $10.7M.
  • Blue Chip Partners first reported a position in Medtronic in Q3 2017 and held it in 21 quarters.
  • Blue Chip Partners's Medtronic position peaked at $16.2M in Q3 2021.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Blue Chip Partners's 13F filing for Q4 2022, filed 1 Feb 2023.